Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Its nice to hear 8.50 share price

<< Previous

Bullboard Posts

Next >>

Comment by Blackbearon Jan 06, 2021 1:19pm

245 Views

Post# 32234077

RE:RE:RE:Its nice to hear 8.50 share price

Snowdrift, Just an FYI on your transfer of onc into your TFSA......yes you can claim your loss on your transfer.....when you move shares into your Tfsa they have to be treated as being sold first...you must claim a gain...if you have one ...or you can claim the loss....please look into the rules of the Tfsa....save yourself some $$$$$$$......

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?